6,971 reports of this reaction
6.6% of all METFORMIN HCL reports
#1 most reported adverse reaction
BLOOD GLUCOSE INCREASED is the #1 most commonly reported adverse reaction for METFORMIN HCL, manufactured by Ascend Laboratories, LLC. There are 6,971 FDA adverse event reports linking METFORMIN HCL to BLOOD GLUCOSE INCREASED. This represents approximately 6.6% of all 105,459 adverse event reports for this drug.
Patients taking METFORMIN HCL who experience blood glucose increased should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
BLOOD GLUCOSE INCREASED is moderately reported among METFORMIN HCL users, representing a notable but not dominant share of adverse events.
In addition to blood glucose increased, the following adverse reactions have been reported for METFORMIN HCL:
The following drugs have also been linked to blood glucose increased in FDA adverse event reports:
BLOOD GLUCOSE INCREASED has been reported as an adverse event in 6,971 FDA reports for METFORMIN HCL. This does not prove causation, but indicates an association observed in post-market surveillance data.
BLOOD GLUCOSE INCREASED accounts for approximately 6.6% of all adverse event reports for METFORMIN HCL, making it one of the most commonly reported side effect.
If you experience blood glucose increased while taking METFORMIN HCL, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.